BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35304136)

  • 21. Factors other than the Duke criteria associated with infective endocarditis among injection drug users.
    Palepu A; Cheung SS; Montessori V; Woods R; Thompson CR
    Clin Invest Med; 2002 Aug; 25(4):118-25. PubMed ID: 12220038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs.
    Schranz AJ
    Clin Infect Dis; 2020 Jul; 71(3):572-573. PubMed ID: 31504337
    [No Abstract]   [Full Text] [Related]  

  • 23. Impact of a Plan of Care Protocol on Patient Outcomes in People Who Inject Drugs With Infective Endocarditis.
    Cooksey GE; Epps JL; Moye RA; Patel N; Shorman MA; Veve MP
    J Infect Dis; 2020 Sep; 222(Suppl 5):S506-S512. PubMed ID: 32877564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcome and prognostic factors of patients with right-sided infective endocarditis requiring intensive care unit admission.
    Georges H; Leroy O; Airapetian N; Lamblin N; Zogheib E; Devos P; Preau S;
    BMC Infect Dis; 2018 Feb; 18(1):85. PubMed ID: 29466956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility and Safety of Outpatient Parenteral Antimicrobial Therapy in Conjunction With Addiction Treatment for People Who Inject Drugs.
    Price CN; Solomon DA; Johnson JA; Montgomery MW; Martin B; Suzuki J
    J Infect Dis; 2020 Sep; 222(Suppl 5):S494-S498. PubMed ID: 32877541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Not Just Endocarditis: Hospitalizations for Selected Invasive Infections Among Persons With Opioid and Stimulant Use Diagnoses-North Carolina, 2010-2018.
    Sredl M; Fleischauer AT; Moore Z; Rosen DL; Schranz AJ
    J Infect Dis; 2020 Sep; 222(Suppl 5):S458-S464. PubMed ID: 32877536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.
    Fernández Guerrero ML; González López JJ; Goyenechea A; Fraile J; de Górgolas M
    Medicine (Baltimore); 2009 Jan; 88(1):1-22. PubMed ID: 19352296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospective Cohort Study of Infective Endocarditis in People Who Inject Drugs.
    Pericàs JM; Llopis J; Athan E; Hernández-Meneses M; Hannan MM; Murdoch DR; Kanafani Z; Freiberger T; Strahilevitz J; Fernández-Hidalgo N; Lamas C; Durante-Mangoni E; Tattevin P; Nacinovich F; Chu VH; Miró JM;
    J Am Coll Cardiol; 2021 Feb; 77(5):544-555. PubMed ID: 33538252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection Drug Use and Outcomes After Surgical Intervention for Infective Endocarditis.
    Shrestha NK; Jue J; Hussain ST; Jerry JM; Pettersson GB; Menon V; Navia JL; Nowacki AS; Gordon SM
    Ann Thorac Surg; 2015 Sep; 100(3):875-82. PubMed ID: 26095108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multivalve infective endocarditis in intravenous drug using patients: an epidemiological study.
    Khan I; Brookes E; Yaftian N; Wilson A; Darby J; Newcomb A
    QJM; 2022 Jul; 115(7):463-468. PubMed ID: 34487178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy.
    Heldman AW; Hartert TV; Ray SC; Daoud EG; Kowalski TE; Pompili VJ; Sisson SD; Tidmore WC; vom Eigen KA; Goodman SN; Lietman PS; Petty BG; Flexner C
    Am J Med; 1996 Jul; 101(1):68-76. PubMed ID: 8686718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular access strategy for delivering long-term antimicrobials to patients with infective endocarditis: device type, risk of infection and mortality.
    Ahmed FZ; Baig WW; Munyombwe T; West R; Sandoe JA
    J Hosp Infect; 2013 Jan; 83(1):46-50. PubMed ID: 23153817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death.
    Regueiro A; Linke A; Latib A; Ihlemann N; Urena M; Walther T; Husser O; Herrmann HC; Nombela-Franco L; Cheema AN; Le Breton H; Stortecky S; Kapadia S; Bartorelli AL; Sinning JM; Amat-Santos I; Munoz-Garcia A; Lerakis S; Gutiérrez-Ibanes E; Abdel-Wahab M; Tchetche D; Testa L; Eltchaninoff H; Livi U; Castillo JC; Jilaihawi H; Webb JG; Barbanti M; Kodali S; de Brito FS; Ribeiro HB; Miceli A; Fiorina C; Dato GM; Rosato F; Serra V; Masson JB; Wijeysundera HC; Mangione JA; Ferreira MC; Lima VC; Carvalho LA; Abizaid A; Marino MA; Esteves V; Andrea JC; Giannini F; Messika-Zeitoun D; Himbert D; Kim WK; Pellegrini C; Auffret V; Nietlispach F; Pilgrim T; Durand E; Lisko J; Makkar RR; Lemos PA; Leon MB; Puri R; San Roman A; Vahanian A; Søndergaard L; Mangner N; Rodés-Cabau J
    JAMA; 2016 Sep; 316(10):1083-92. PubMed ID: 27623462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of infective endocarditis with focus on non-device related right-sided infective endocarditis: A retrospective register-based study in the region of Southern Denmark.
    Lassen H; Nielsen SL; Gill SUA; Johansen IS
    Int J Infect Dis; 2020 Jun; 95():224-230. PubMed ID: 32289560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infective endocarditis in intravenous drug abusers: clinical challenges emerging from a single-centre experience.
    Scheggi V; Del Pace S; Ceschia N; Vanni F; Merilli I; Sottili E; Salcuni L; Zoppetti N; Alterini B; Cerillo A; Marchionni N; Stefàno PL
    BMC Infect Dis; 2021 Sep; 21(1):1010. PubMed ID: 34579674
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence and Risk Factors for Unplanned Catheter Removal in a PICU: Central Venous Catheters Versus Peripherally Inserted Central Venous Catheters.
    Shimizu Y; Hatachi T; Takeshita J; Inata Y; Kyogoku M; Aoki Y; Taniguchi M; Kawamura A; Okumura J; Takeuchi M
    Pediatr Crit Care Med; 2020 Sep; 21(9):e635-e642. PubMed ID: 32433440
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evolving mortality rates in people who inject drugs: An Australian tertiary hospital observational study on infective endocarditis.
    Khan I; Brookes E; Santamaria J; Crisafi D; Wilson A; Darby J; Newcomb A
    PLoS One; 2022; 17(8):e0270283. PubMed ID: 36018847
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current profile of infective endocarditis in intravenous drug users: The prognostic relevance of the valves involved.
    Ortiz-Bautista C; López J; García-Granja PE; Sevilla T; Vilacosta I; Sarriá C; Olmos C; Ferrera C; Sáez C; Gómez I; San Román JA
    Int J Cardiol; 2015; 187():472-4. PubMed ID: 25846656
    [No Abstract]   [Full Text] [Related]  

  • 39. Safe and successful treatment of intravenous drug users with a peripherally inserted central catheter in an outpatient parenteral antibiotic treatment service.
    Ho J; Archuleta S; Sulaiman Z; Fisher D
    J Antimicrob Chemother; 2010 Dec; 65(12):2641-4. PubMed ID: 20864497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long term surgical outcomes for infective endocarditis in people who inject drugs: a systematic review and meta-analysis.
    Goodman-Meza D; Weiss RE; Gamboa S; Gallegos A; Bui AAT; Goetz MB; Shoptaw S; Landovitz RJ
    BMC Infect Dis; 2019 Nov; 19(1):918. PubMed ID: 31699053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.